Tag: cell viability assays market drivers

  • Cell Viability Assays Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theCell Viability Assays Market?

    The surge in cell-based therapeutics is anticipated to boost the expansion of the cell viability assay market. These therapeutics use live cells to mend or supersede damaged tissues, cure diseases, or reinstate normal functions. They are driven by biotechnological progress, more funding in regenerative medicine, the rising acceptance and implementation of cell therapies, and advancements in cell engineering and manufacturing techniques. Cell viability assays are crucial to cell-based treatments as they ensure the health, functionality, and safety of therapeutic cells, thereby boosting the effectivity of treatments and quality check. For example, the US-based non-profit medical and scientific organization, the American Society of Gene & Cell Therapy, reported a rise of seven trials in non-genetically modified cell therapies from Q4 2022 to 38 in Q1 2023. Consequently, the growth of cell-based therapeutics is fueling the extension of the cell viability assay market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

    #What is the Projected CAGR for the Cell Viability Assays Market Size from 2025 to 2034?

    In recent times, there has been substantial expansion in the market size of cell viability assays. Its anticipated growth is from a value of $1.56 billion in 2024 to a value of $1.73 billion in 2025, maintaining a compound annual growth rate (CAGR) of 10.8%. This growth in the historical period can be traced back to an upswing in cancer research funding, an increase in the expenditure for R&D in pharmaceuticals, the growth in the biotech industry, advancements in cell culture techniques, a surge in demand for stem cell research, a heightened requirement for toxicity testing, an increase in the application of real time cell analysis systems, and a rise in the quantity of CROs (contract research organizations).

    The market for cell viability assays is projected to experience accelerated growth in the upcoming years, reaching a valuation of $2.58 billion in 2029, with a compound annual growth rate of 10.5%. The anticipated growth over the forecast period is primarily due to factors such as the increased demand for personalized medicine, a surge in government funding for cell-based research, a heightened emphasis on precision medicine, and development in stem cell research and its applications. Other contributing factors include a more wide-spread availability of automated cell viability analyzers, a rising incidence of infectious diseases, greater focus on enhancing the accuracy and sensitivity of assays, growing awareness of cell viability assays’ advantages, and advancements in organ-on-a-chip technologies and regenerative medicine. Key trends expected during the forecast period involve progress in high throughput screening methods, the application of AI and machine learning algorithms, the creation of real-time monitoring systems, and the adoption of automated liquid handling systems. Additionally, stride in multiplex assays to measure cell viability concurrently, the opting for sustainable and environmentally friendly reagents, the introduction of user-friendly assay kits, progress in electrochemical assays, the implementation of scalable cell viability assays, and the designing of assays which are compatible with primary and stem cells, is also anticipated.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014

    What Are the Current Market Growth and Trends in theCell Viability Assays Market That Industry Players Should Watch?

    Key players in the cell viability assays market are creating novel cell screening technologies to enhance precision and accelerate the process of drug discovery. By facilitating high-throughput, accurate, and rapid evaluation of cell health and responses, these technologies improve cell viability assays, thereby refining experimental conditions and contributing to better therapeutic strategy development. In May 2024, for example, German technology firm Arralyze released CellShepherd, a state-of-the-art single-cell analysis platform. By using proprietary nanowell glass arrays, this platform miniaturizes cell-based assays for real-time tracking. Its autonomous functionality includes accurate cell dispensing, sterile co-culturing conditions, and imaging with brightfield and fluorescent channels. Furthermore, the AI-enabled analysis provides precise cell counting and tracking. Catering to the growing demand for exact single-cell research in biomedical and life science fields, this easy-to-use platform is highly beneficial.

    What Are the Major Market Players Making an Impact on theCell Viability Assays Market Growth?

    Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

    How Are the Key Segments of the Cell Viability Assays Market Driving Opportunities and Innovations?

    The cell viability assays market covered in this report is segmented –

    1) By Product: Consumables, Instruments

    2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

    3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

    Subsegments:

    1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

    2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

    What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theCell Viability Assays Market?# Market Expansion?

    North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Cell Viability Assays Market 2025, By The Business Research Company:

    Cell Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

    Cellular Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

    Stem Cell Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • In-Depth Insights into the Cell Viability Assays Market: Growth, Trends, and Opportunities for 2025-2034

    In-Depth Insights into the Cell Viability Assays Market: Growth, Trends, and Opportunities for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the cell viability assays market size evolved in recent years?

    The cell viability assays market has seen rapid growth in recent years. It is expected to grow from $1.56 billion in 2024 to $1.73 billion in 2025, at a compound annual growth rate (CAGR) of 10.8%. This growth is attributed to increased investment in cancer research, rising pharmaceutical R&D expenditure, growth in the biotechnology sector, advancements in cell culture techniques, and the increasing demand for stem cell research and toxicity testing.

    What are the predictions for the cell viability assays market size in the coming years?

    The cell viability assays market is expected to grow rapidly, reaching $2.58 billion by 2029 at a CAGR of 10.5%. This growth is driven by factors such as the increasing demand for personalized medicine, greater government funding for cell-based research, and advances in stem cell research. Other contributing factors include the rising availability of automated cell viability analyzers, a growing focus on precision medicine, the development of organ-on-a-chip technologies, and rising demand for regenerative medicine. Key trends include the adoption of high-throughput screening methods, AI and machine learning algorithms, real-time monitoring systems, and eco-friendly reagents.

    Get your cell viability assays market report here!

    https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

    What key factors are fueling the growth of the cell viability assays market?

    The rising use of cell-based therapeutics is expected to drive the growth of the cell viability assay market. These treatments use living cells to repair tissue, treat diseases, and restore normal function, supported by advances in biotechnology, regenerative medicine investment, and improved cell engineering. Cell viability assays are essential for ensuring the health and safety of therapeutic cells, optimizing treatment efficacy and quality control. For instance, in Q1 2023, the American Society of Gene & Cell Therapy reported 38 trials for non-genetically modified cell therapies, a rise from 31 in Q4 2022. Thus, cell-based therapeutics are propelling the growth of the cell viability assay market.

    How is the global cell viability assays market divided into key segments?

    The cell viability assays market covered in this report is segmented –

    1) By Product: Consumables, Instruments

    2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

    3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

    Subsegments:

    1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

    2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

    Who are the key firms paving the way for growth in the cell viability assays market?

    Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

    Which trends are expected to transform the cell viability assays market?

    Companies in the cell viability assays market are focusing on innovative cell screening technologies to improve the accuracy and speed of drug discovery. These technologies enable high-throughput, precise, and rapid analysis of cell health, improving experimental conditions and therapeutic strategies. For example, in May 2024, Germany-based Arralyze introduced CellShepherd, a platform for single-cell analysis. The platform uses nanowell glass arrays for real-time monitoring, providing precise cell dispensing and imaging while using AI for accurate cell counting and tracking.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014

    What regions are contributing significantly to the growth of the cell viability assays market?

    North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Cell Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

    Cellular Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

    Stem Cell Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Outlook of the Cell Viability Assays Market: Growth, Trends, and Emerging Opportunities Explored

    Future Outlook of the Cell Viability Assays Market: Growth, Trends, and Emerging Opportunities Explored

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Expected Growth Rate of the Cell Viability Assays Market Based on Industry Projections?

    In recent times, the market size for cell viability assays has experienced a significant surge. Projected growth sees it escalating from $1.56 billion in 2024 to $1.73 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. Various factors have contributed to historical growth, including increased funding for cancer research, a rise in pharmaceutical R&D expenses, expansion in the biotech sector, advancements in cell culture methodologies, a heightened demand for stem cell research, an increased necessity for toxicity testing, a surge in the usage of real-time cell analysis systems, and an increase in the quantity of contract research organizations (CROs).

    Expectations for the cell viability assays market size foresee a quickened expansion in the coming years. Its value is projected to reach $2.58 billion by 2029 with a compound annual growth rate (CAGR) of 10.5%. Various factors contributing to growth during the prediction period include the rising requirement for tailor-made medicine, augmented government support for cell-based research, an amplified emphasis on precision medicine, advancements in stem cell research and utilization, the increase in automated cell viability analyzers, growing instances of infectious diseases, a heightened interest in enhancing assay accuracy and sensitivity, increased consciousness about cell viability assays benefits, and enhancement in organ on a chip technology development. The expected trends for this period encompass advancements in high throughput screening techniques, the application of AI and machine learning algorithms, the emergence of real-time monitoring systems, incorporation of automated liquid handling systems, the creation of multiplex assays for simultaneous cell viability measurement, use of more sustainable and eco-conscious reagents, the introduction of user-friendly assay kits, enhancements in electrochemical assays, the application of scalable cell viability assays, as well as the development of assays compatible with primary cells and stem cells.

    What Key Drivers Are Accelerating the Growth of the Cell Viability Assays Market During the Forecast Period?

    The rise in cell-based therapeutics is anticipated to boost the cell viability assay market’s advancement. Cell-based therapeutics entail the use of live cells to repair or replace damaged tissue, tackle diseases, or restore regular function. The surge in these therapies is propelled by advancements in biotechnology, rising investments in regenerative medicine, growing acceptance and adoption of cell therapies, as well as enhancements in cell engineering and production technologies. In order to optimize treatment efficacy and quality control, cell viability assays are necessary for ensuring the health, functionality, and safety of therapeutic cells. For example, the American Society of Gene & Cell Therapy, a non-profit medical and scientific organization based in the US, reported that 38 trials commenced for non-genetically modified cell therapies in Q1 2023, an increase of 7 from Q4 2022. As such, the expansion of cell-based therapeutics is fuelling the growth of the cell viability assay market.

    Get Your Free Sample of the Global Cell Viability Assays Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

    What Companies Are At the Forefront of Innovation in the Cell Viability Assays Market?

    Major companies operating in the cell viability assays market are:

    • Thermo Fisher Scientific Inc.

    • Danaher Corporation

    • Merck KGaA

    • Becton

    • Dickinson

    How Are Emerging Trends in Consumer Behavior Affecting the Cell Viability Assays Market?

    Leading businesses in the cell viability assays market are introducing advanced cell screening techniques to boost precision and expedite the process of drug discovery. These technologies augment cell viability assays by facilitating a swift, precise, and high-throughput evaluation of cell health and responses, thereby refining experimental parameters and aiding in the formulation of superior therapeutic strategies. For instance, in May 2024, the technology firm based in Germany, Arralyze, launched CellShepherd, a state-of-the-art platform for single-cell analysis. This platform employs exclusive nanowell glass arrays to shrink cell-based assays for real-time monitoring. The self-reliant system provides accurate cell dispensing, co-culturing in sterile environments, and imaging via both brightfield and fluorescent channels. The platform’s AI-powered analysis ensures precise cell counting and tracking. This easy-to-use platform addresses the growing demand for accurate single-cell research in life science and biomedical domains.

    Get Instant Access to the Global Cell Viability Assays Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

    Which Key Segments of the Cell Viability Assays Market Are Poised for Growth and Innovation?

    The cell viability assays market covered in this report is segmented –

    1) By Product: Consumables, Instruments

    2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

    3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

    Subsegments:

    1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

    2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

    What Regions Are Propelling Growth in the Cell Viability Assays Industry?

    North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Key Parameters Define the Cell Viability Assays Market’s Scope?

    Cell viability assays are methods used to determine the ability of cells, tissues, or organs to maintain or recover a state of survival. Cell viability assays are used to evaluate the best growth conditions for cells in culture in response to external stimuli, chemicals, and medicinal treatments when determining optimal growth conditions in cell culture.

    Browse Through More Similar Reports By The Business Research Company:

    Cell Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

    Cellular Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

    Stem Cell Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Cell Viability Assays Market 2024

    5 Key Insights On The Cell Viability Assays Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Cell Viability Assays Global Market Report 2024, the cell viability assays market is expected to show significant growth in the forecast period.

    The cell viability assays market has experienced significant growth, increasing from $1.41 billion in 2023 to $1.56 billion in 2024 at a CAGR of 10.5%. This growth is projected to continue, reaching $2.34 billion by 2028 with a CAGR of 10.6%.

    Key Drivers of Growth

    • Investment in Cancer Research:
      • Increased funding and research initiatives targeting cancer have propelled the demand for cell viability assays.
    • Pharmaceutical R&D Expenditure:
      • Rising investment in pharmaceutical research and development has driven the market forward.
    • Biotechnology Sector Expansion:
      • Growth in the biotechnology sector has significantly contributed to the market’s expansion.
    • Advancements in Cell Culture Techniques:
      • Improvements in cell culture techniques have enhanced the accuracy and efficiency of cell viability assays.
    • Stem Cell Research Demand:
      • Increasing interest in stem cell research has led to a higher demand for cell viability assays.
    • Need for Toxicity Testing:
      • The necessity for rigorous toxicity testing in drug development has fueled market growth.
    • Real-Time Cell Analysis Systems:
      • The rise in utilization of real-time cell analysis systems has optimized the efficiency of cell viability assays.
    • Contract Research Organizations (CROs):
      • The growing number of CROs has expanded the availability and accessibility of cell viability assays.

    View More On The Cell Viability Assays Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

    Future Growth Prospects
    The forecast period is expected to see rapid growth due to several factors:

    • Personalized Medicine:
      • Increasing demand for personalized medicine is driving the market.
    • Government Funding for Cell-Based Research:
      • Enhanced government funding is supporting cell-based research initiatives.
    • Precision Medicine Focus:
      • A greater emphasis on precision medicine is boosting market growth.
    • Stem Cell Research and Applications:
      • Continued advancements and applications in stem cell research are propelling the market forward.
    • Automated Cell Viability Analyzers:
      • Increasing availability of automated analyzers is improving assay efficiency.
    • Infectious Disease Incidence:
      • A rise in the incidence of infectious diseases is elevating the demand for cell viability assays.
    • Improved Assay Accuracy and Sensitivity:
      • Focus on enhancing assay accuracy and sensitivity is driving market growth.
    • Awareness of Assay Benefits:
      • Growing awareness about the advantages of cell viability assays is boosting market adoption.
    • Organ on a Chip Technologies:
      • Development of organ on a chip technologies is expected to drive the market.
    • Regenerative Medicine Demand:
      • Increasing demand for regenerative medicine is contributing to market growth.

    Emerging Trends

    • High Throughput Screening Methods:
      • Advances in high throughput screening methods are revolutionizing the market.
    • AI and Machine Learning:
      • Implementation of AI and machine learning algorithms is enhancing assay accuracy.
    • Real-Time Monitoring Systems:
      • Development of real-time monitoring systems is improving cell viability assays.
    • Automated Liquid Handling Systems:
      • Adoption of automated liquid handling systems is increasing assay efficiency.
    • Multiplex Assays:
      • Development of multiplex assays allows simultaneous measurement of cell viability.
    • Eco-Friendly Reagents:
      • Adoption of more sustainable and eco-friendly reagents is a key trend.
    • User-Friendly Assay Kits:
      • Development of user-friendly assay kits is making cell viability assays more accessible.
    • Electrochemical Assays:
      • Advancements in electrochemical assays are enhancing the market.
    • Scalable Cell Viability Assays:
      • Implementation of scalable assays is addressing growing demand.
    • Compatibility with Primary Cells and Stem Cells:
      • Development of assays compatible with primary and stem cells is driving innovation.

    Role of Cell-Based Therapeutics
    Cell-based therapeutics are driving the growth of the cell viability assays market. These treatments use living cells to repair or replace damaged tissue and treat diseases. Advances in biotechnology, investment in regenerative medicine, and improvements in cell engineering are fueling this growth. For instance, 38 trials for non-genetically modified cell therapies were initiated in Q1 2023, highlighting the increasing adoption of cell-based therapeutics.

    Major Players in the Market
    Key companies in the cell viability assays market include:

    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Becton, Dickinson, and Company
    • Agilent Technologies Inc.
    • Lonza Group Ltd.
    • PerkinElmer Inc.
    • Sartorius AG
    • Charles River Laboratories
    • Bio-Rad Laboratories Inc.

    Innovative Technologies in Drug Discovery
    Companies are developing innovative cell screening technologies to improve drug discovery. For example, Arralyze introduced CellShepherd in May 2024, a platform for single-cell analysis using proprietary nanowell glass arrays, enhancing real-time monitoring and analysis.

    Strategic Acquisitions
    BD Biosciences acquired Cytognos in February 2022 to expand its portfolio in blood cancer diagnostics and immune monitoring. This acquisition highlights the strategic moves by companies to strengthen their market position.

    Market Segmentation

    • By Product: Consumables, Instruments
    • By Application: Basic Research, Stem Cell Research, Drug Discovery and Development, Clinical and Diagnostic Applications, Other Applications
    • By End-User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End-Users

    North America was the largest region in the market in 2023, with Asia-Pacific expected to be the fastest-growing region in the forecast period.

    Request A Sample Of The Global Cell Viability Assays Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=16014&type=smp